One aspect that's worth mentioning imo is that while a percentage of people has been reported not to develop anti-spike antibodies at a measurable level [1], other factors come into play as well.
- Antibody levels after natural infection wane [2] with seroreversion (like seroconversion but the other way around) being common - Some tests used by researchers have low sensitivity (especially many weeks after infection) - Qualitative assays may return negative results even though antibodies may be detected through other methods [3] - There are multiple targets that people may develop antibodies against, testing only for one target like N or S is not conclusive [4, since I can't seem to find a better study on this topic I saw earlier this week]
[1]: https://pubmed.ncbi.nlm.nih.gov/34716320/ [2]: https://www.nature.com/articles/s41598-021-94453-5 [3]: https://pubmed.ncbi.nlm.nih.gov/34213733/ [4]: https://insight.jci.org/articles/view/142386